Table 2 Incidence of fever reported during the 15-day (days 0–14) and results of between-group exploratory analyses, post-dose 1 (total vaccinated cohort)
n (%) | Difference in percentage (Var-HSA minus Var + HSA), % (95% CI) | ||
|---|---|---|---|
Group Var-HSA | Group Var + HSA | ||
Post-dose 1 | N = 612 | N = 614 | |
Any | 83 (13.6) | 92 (15.0) | −1.42 (−5.36–2.51) |
≥38.0 °C | 83 (13.6) | 92 (15.0) | −1.42 (−5.36–2.51) |
related | 53 (8.7) | 33 (5.4) | 3.29 (0.43–6.23) |
> 38.5 °C | 42 (6.9) | 45 (7.3) | −0.47 (−3.39–2.45) |
related | 21 (3.4) | 14 (2.3) | 1.15 (−0.75–3.15) |
> 39.0 °C | 24 (3.9) | 32 (5.2) | −1.29 (−3.72–1.08) |
related | 12 (2) | 10 (1.6) | 0.33 (−1.25–1.96) |
> 39.5 °C | 18 (2.9) | 13 (2.1) | 0.82 (−0.99–2.71) |
related | 9 (1.5) | 1 (0.2) | 1.31 (0.38–2.63) |
> 40.0 °C | 5 (0.8) | 5 (0.8) | 0 (−1.17–1.18) |
related | 1 (0.2) | 0 (0.0) | 0.16 (−0.46–0.92) |
Medical advice | 19 (3.1) | 28 (4.6) | −1.46 (−3.72–0.72) |